ISOFORM 1 as A Drug Target Or Biomarker for Milk Ovulation Inhibitors

Target Name: Prolactin receptor (isoform 1)

NCBI ID: P3824

Prolactin receptor (isoform 1)

Other Name(s): secreted prolactin binding protein | truncated prolactin receptor | hPRL receptor | PRL-R

ISOFORM 1 as A Drug Target Or Biomarker for Milk Ovulation Inhibitors

Prolactin Receptor (ISOFORM 1) as a Drug Target or Biomarker: A Promising Approach for the Treatment of Milk Ovulation Inhibitors

Prolactin (PRL) is a hormone produced by the pituitary gland that plays a critical role in the development and maintenance of milk production in lactating females. The PRL receptor, also known as ISOFORM 1, is a transmembrane protein that plays a crucial role in the regulation of milk production and ovulation in lactating females. The ISOFORM 1 receptor is also an attractive drug target or biomarker for the treatment of milk ovulation inhibitors, which are commonly used to prevent milk production in lactating females, such as condoms, tampons, and diaphragms.

The Prolactin Receptor as a Drug Target

The PRL receptor is a protein that is expressed in various tissues, including the brain, pituitary gland, and ovaries. The ISOFORM 1 receptor is a glycoprotein that consists of four transmembrane domains: a N-terminus, a T-terminus, a middle membrane domain, and an C-terminus. The ISOFORM 1 receptor plays a critical role in the regulation of milk production by interacting with specific intraglandular signaling pathways.

Recent studies have shown that the ISOFORM 1 receptor is involved in the regulation of milk production and ovulation in lactating females. The ISOFORM 1 receptor is a strong candidate for a drug target because it has a clear function in the regulation of milk production and can be modulated to prevent milk production. Therefore, compounds that can interact with the ISOFORM 1 receptor and prevent milk production could be useful for the treatment of milk ovulation inhibitors.

The Prolactin Receptor as a Biomarker

The ISOFORM 1 receptor is also an attractive biomarker for the treatment of milk ovulation inhibitors because it is highly expressed in various tissues and can be used as a target for diagnostic tests. The ISOFORM 1 receptor is also expressed in the brain, which suggests that it may be involved in the regulation of milk production and ovulation in lactating females. Therefore, measuring the level of ISOFORM 1 receptor expression in lactating females could be a useful diagnostic tool for the evaluation of milk ovulation inhibitors.

The Prolactin Receptor as a Potential Drug Target

In conclusion, the ISOFORM 1 receptor is a promising drug target and biomarker for the treatment of milk ovulation inhibitors. The ISOFORM 1 receptor plays a critical role in the regulation of milk production and ovulation in lactating females, making it an attractive target for small molecules that can interact with the ISOFORM 1 receptor and prevent milk production. Further research is needed to understand the full function of the ISOFORM 1 receptor and to develop effective compounds that can interact with the ISOFORM 1 receptor to prevent milk production.

Protein Name: Prolactin Receptor (isoform 1)

The "Prolactin receptor (isoform 1) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Prolactin receptor (isoform 1) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets